Litigation Details for Arena Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Arena Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-03-06 |
| Court | District Court, D. Delaware | Date Terminated | 2019-03-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | None | Referred To | |
| Parties | TEVA PHARMACEUTICALS USA, INC. | ||
| Patents | 6,953,787; 7,514,422; 7,977,329; 8,168,624; 8,207,158; 8,273,734; 8,367,657; 8,546,379; 8,575,149; 8,697,686; 8,946,207; 8,980,881; 8,999,970; 9,169,213 | ||
| Attorneys | Bruce M. Wexler; Karen Elizabeth Keller | ||
| Firms | Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Details for Arena Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-03-28 | 12 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,168,624 B2; US 8,367,657 …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware | External link to document | |
| 2017-03-28 | 13 | 21, 2017. Date of Expiration of Patent: April 18, 2029 re: US 8,168,624 B2. (Keller, Karen) (Entered: 03… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware | External link to document | |
| 2017-03-28 | 14 | 21, 2017. Date of Expiration of Patent: April 10, 2023 re: US 8,367,657 B2. (Keller, Karen) (Entered: 03… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2017 5 March 2019 1:17-cv-00231 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
